SFI Acquires ProThera to Strengthen Global Position in Clinically Proven Natural Medicine

Jul 01, 2013, 12:52 ET from Soho Flordis International (SFI)

RENO, Nevada, July 1, 2013 /PRNewswire/ --

Soho Flordis International (SFI), an international provider of clinically proven natural medicines, announced today the acquisition of ProThera, a leading nutraceutical company based in Reno, Nevada. The acquisition marks an important milestone in establishing SFI as the leading global provider of clinically proven natural medicine.

With over 50 years of formulation experience and a comprehensive product line of probiotics and dietary supplements distributed exclusively by healthcare providers, ProThera gives SFI entry into both the growing field of probiotics and the U.S. market, further delivering on its mission to give healthcare providers and patients access to the best natural medicine supported by clinical studies.  

ProThera headquarters in Reno, Nevada will serve as a regional hub for the rapid commercialization of the extensive SFI Group product portfolio and future pipeline.

In a corresponding move, SFI today announced the acquisition of Ginsana, a leader and innovator in natural medicine products based in Bioggio, Switzerland. Owned by Pharmaton, a Boehringer Ingelheim Group company, Ginsana brings superior expertise, state-of-the-art  facilities and a complementary line of six natural medicine brands with significant growth potential to the SFI portfolio. Ginsana will continue to market its products under the Ginsana brand name and manufacture world class natural medicines. The trademark rights of Pharmaton remain at Pharmaton.

"The parallel acquisition of ProThera and Ginsana not only gives us entry into the attractive field of probiotics, it has extended our network and pipeline of natural medicine brands with a great legacy," said SFI CEO, Nigel Pollard. "Building on our success in the southern hemisphere - in Australia and South Africa - we have now established a strong foundation for expansion in the northern hemisphere and its main markets, the U.S., Europe, Middle East and Asia. Both companies reflect SFI's dedication to innovation and the advancement of natural medicines through healthcare providers."

About SFI
Soho Flordis International (SFI) is an international provider of clinically proven natural medicines. An Australian registered company, SFI is committed to ensuring that people globally have access to the best natural medicines supported by clinical studies performed on the exact finished product. Rather than based claims on highly variable ingredients this higher standard enables the selection of safe, appropriate and effective treatments.

SFI is expanding its global presence to achieve its vision of building the world's leading global brands focused on bringing quality, evidence-based natural medicines to market through healthcare professionals, supported by leading edge research and endorsed by world-class opinion leaders.

About Prothera

ProThera, Incorporated is a nutritionally focused healthcare company that specializes in the formulation and manufacture of nutraceuticals for exclusive distribution by healthcare professionals.

About Ginsana

Ginsana SA, owned by Pharmaton, a Boehringer Ingelheim Group company located in Bioggio (Switzerland), operates in the high-quality natural health sector, comprising pharmaceutical products made using natural substances and extracts. Ginsana's products are the result of the most rigorous scientific research and experience acquired over many years as well as the skills developed within the Boehringer Ingelheim Group.

Media Contact
Wolfgang Kuchen, Director Integration, SFI
Phone: +1801-859-9700
Email: Wolfgang.Kuchen@sfihealth.com

SOURCE Soho Flordis International (SFI)